Search Results - Drug Therapy
Suggested Topics within your search.
Suggested Topics within your search.
- genetics
- drug therapy 120
- Cancer 70
- Genetic aspects 66
- Neoplasms 63
- Chemotherapy 46
- methods 43
- therapeutic use 40
- Antineoplastic Agents 39
- Pharmacogenetics 35
- Treatment 30
- therapy 30
- drug effects 29
- Antineoplastic agents 26
- diagnosis 23
- pharmacology 22
- metabolism 21
- Biochemical markers 18
- Breast Neoplasms 18
- Drug Discovery 18
- Drugs 18
- antagonists & inhibitors 18
- Diseases 17
- physiology 16
- Biomarkers 15
- Metabolism 15
- Molecular Targeted Therapy 15
- complications 15
- Drug development 14
- Precision Medicine 14
-
1
Pharmacogenomics in cancer therapy
Published 2015Table of Contents: “…Contents: Pharmacogenomics in cancer therapy -- Types and sources of genetic variation -- Adverse drug reactions -- Techniques to measure genetic variation -- Cancer pharmacogenomics and drug selection -- Cancer pharmacogenomics and drug toxicity -- Irinotecan (CPT-11) pathway -- Cancer pharmacogenomics and drug outcomes -- Tamoxifen pathway -- Uses of pharmacogenomics.…”
Get full text
Series
Electronic Video -
2
Pharmacogenomics in cancer therapy
Published 2015Table of Contents: “…Contents: Pharmacogenomics in cancer therapy -- Types and sources of genetic variation -- Adverse drug reactions -- Techniques to measure genetic variation -- Cancer pharmacogenomics and drug selection -- Cancer pharmacogenomics and drug toxicity -- Irinotecan (CPT-11) pathway -- Cancer pharmacogenomics and drug outcomes -- Tamoxifen pathway -- Uses of pharmacogenomics.…”
Get full text
Series
Electronic Video -
3
Pharmacogenomics in cancer therapy
Published 2015Table of Contents: “…Contents: Pharmacogenomics in cancer therapy -- Types and sources of genetic variation -- Adverse drug reactions -- Techniques to measure genetic variation -- Cancer pharmacogenomics and drug selection -- Cancer pharmacogenomics and drug toxicity -- Irinotecan (CPT-11) pathway -- Cancer pharmacogenomics and drug outcomes -- Tamoxifen pathway -- Uses of pharmacogenomics.…”
Get full text
Series
Electronic Video -
4
Germline pharmacogenomics as a tool to individualize therapy in breast cancer
Published 2009Subjects: “…Breast Neoplasms drug therapy.…”
Get full text
Series
Electronic Video -
5
Genetic determinants of metabolism clinical applications in psychiatry /
Published 2007Subjects: “…Mental Disorders drug therapy.…”
Get full text
Series
Electronic Video -
6
Role of molecular markers in guiding therapy in cancer
Published 2015Subjects: Get full text
Series
Electronic Video -
7
Pharmacogenetics progress, pitfalls and clinical potential /
Published 2008Subjects: “…Cardiovascular Diseases drug therapy.…”
Get full text
Series
Electronic Video -
8
Genetic polymorphism of thiopurine methyltransferase and thiopurine therapy from molecular genetics to clinical medicine /
Published 2009Subjects: Get full text
Series
Electronic Video -
9
CML genetic paradigm of targeted therapy, part 1 of 2 /
Published 2015Subjects: “…Leukemia, Myelogenous, Chronic, BCR-ABL Positive drug therapy.…”
Get full text
Series
Electronic Video -
10
-
11
CML genetic paradigm of targeted therapy, part 2 of 2 /
Published 2015Subjects: “…Leukemia, Myelogenous, Chronic, BCR-ABL Positive drug therapy.…”
Get full text
Series
Electronic Video -
12
Germline pharmacogenomics as a tool to individualize therapy in breast cancer
Published 2009Subjects: “…Breast Neoplasms drug therapy. 113143…”
Get full text
Series
Electronic Video -
13
Germline pharmacogenomics as a tool to individualize therapy in breast cancer
Published 2009Subjects: “…Breast Neoplasms drug therapy. 113143…”
Get full text
Series
Electronic Video -
14
CML genetic paradigm of targeted therapy, part 1 of 2 /
Published 2015Subjects: “…Leukemia, Myelogenous, Chronic, BCR-ABL Positive drug therapy. 100747…”
Get full text
Series
Electronic Video -
15
CML genetic paradigm of targeted therapy, part 1 of 2 /
Published 2015Subjects: “…Leukemia, Myelogenous, Chronic, BCR-ABL Positive drug therapy. 100747…”
Get full text
Series
Electronic Video -
16
Role of molecular markers in guiding therapy in cancer
Published 2015Subjects: Get full text
Series
Electronic Video -
17
Role of molecular markers in guiding therapy in cancer
Published 2015Subjects: Get full text
Series
Electronic Video -
18
UGT1A1 polymorphisms and irinotecan toxicity in colorectal cancer patients
Published 2009Subjects: Get full text
Series
Electronic Video -
19
CML genetic paradigm of targeted therapy, part 2 of 2 /
Published 2015Subjects: “…Leukemia, Myelogenous, Chronic, BCR-ABL Positive drug therapy. 100842…”
Get full text
Series
Electronic Video -
20
CML genetic paradigm of targeted therapy, part 2 of 2 /
Published 2015Subjects: “…Leukemia, Myelogenous, Chronic, BCR-ABL Positive drug therapy. 100842…”
Get full text
Series
Electronic Video